Homeland Infrastructure Foundation-Level Data (HIFLD) geospatial data sets containing information on Pharmacies.

This dataset provides a list of drugstores, pharmacies and licensed pharmacists names in the United States, as well as the territories of American Samoa, Guam, Puerto Rico, the Commonwealth of the Northern Mariana Islands, and the Virgin Islands, with detailed geolocation identifiers such as latitude and longitude of each drugstore or pharmacy, as well as telephone numbers, addresses, website URLs and other provider information.

Forecast: Number of Pharmacist Graduates in the US 2022 - 2026 Discover more data with ReportLinker!

This timeline depicts pharmacy and drug store sales in the United States from 1992 to 2022. In 2022, U.S. pharmacy and drug store sales amounted to about 336 billion U.S. dollars.

U.S. Pharmacies and Drug Stores Industry The retail drug industry is comprised of pharmacies or drugstores, as they are known in North America. With an aging population and greater prevalence of chronic diseases, the need for safe, legal pharmaceutical drugs is constantly rising.Pharmacies and drug stores dispense prescription medications and over-the-counter drugs directly to patients. However, their role is more than one of simple distribution as they dispense medication in specific doses, adhere to optimal conditions of storage and give valuable advice to patients. Pharmacies practice in a wide range of locations such as communities, hospitals, clinics and nursing homes. Other drug retail outlets include supermarkets, and independent and online pharmacies, which offer mail-order drugs to patients, proving especially convenient for those that may be unable to leave their homes. Apart from selling drugs, miscellaneous products also account for a percentage of sales for these retail outlets, such as cosmetics and confectioneries.The retail drug store industry employs many different types of workers. Each store has a manager, along with department managers or assistant managers to handle additional administrative duties. Sales associates are generally entry-level retail workers. Pharmacists require a specialized degree and licensing to dispense medication.

Chemist4U located at 34a-37 Greenhey Place, East, Gillibrands Rd, Skelmersdale WN8 9SA is a registered Pharmacy and NHS Contract Holder. Please can you inform us how many Ozempic and Saxenda have been dispensed for NHS patients under FP10 or other prescriptions. Please can you separate the dispensed items by medications as below and by month. Ozempic 0.25mg/0.19ml solution for injection 1.5ml pre-filled pens Novo Nordisk Ltd Ozempic 0.5mg/0.37ml solution for injection 1.5ml pre-filled pens Novo Nordisk Ltd Ozempic 1mg/0.74ml solution for injection 3ml pre-filled pens Novo Nordisk Ltd. Saxenda 6mg/ml solution for injection 3ml pre-filled pens Novo Nordisk Ltd. This pharmacy has been stockpiling Ozempic and Saxenda during a national shortage, and has claimed that's its stockpile was for NHS patients. The time period was further clarified on 29th September for the data to be provided between January 2019 and August 2023. Response A copy of the information is attached. Please read the below notes to ensure a correct understanding of the data. NHS Prescription Services process prescriptions for Pharmacy Contractors, Appliance Contractors, Dispensing Doctors and Personal Administration with information then used to make payments to pharmacists and appliance contractors in England for prescriptions dispensed in primary care settings (other arrangements are in place for making payments to Dispensing Doctors and Personal Administration). This involves processing over 1 billion prescription items and payments totalling over £9 billion each year. The information gathered from this process is then used to provide information on costs and trends in prescribing in England and Wales to over 25,000 registered NHS and Department of Health and Social Care users. Data Source: ePACT2 Data in ePACT2 is sourced from the NHSBSA Data Warehouse and is derived from products prescribed on prescriptions and dispensed in the Community. The data captured from prescription processing is used to calculate reimbursement and remuneration. It includes items prescribed in England, Wales, Scotland, Northern Ireland, Guernsey / Alderney, Jersey, and Isle of Man which have been dispensed in the community in England. English prescribing that has been dispensed in Wales, Scotland, Guernsey / Alderney, Jersey, and Isle of Man is also included. The Data excludes: • Items not dispensed, disallowed and those returned to the contractor for further clarification. • Prescriptions prescribed and dispensed in Prisons, Hospitals and Private prescriptions. • Items prescribed but not presented for dispensing or not submitted to NHS Prescription Services by the dispenser.

The United States pharmacy management system market is experiencing robust growth, driven by the increasing need for efficient inventory management, enhanced patient safety, and improved operational efficiency within pharmacies. The market's expansion is fueled by several key factors. Firstly, the rising adoption of cloud-based solutions offers scalability, cost-effectiveness, and improved data accessibility, significantly impacting the market's trajectory. Secondly, the increasing prevalence of chronic diseases necessitates streamlined medication management, driving demand for sophisticated pharmacy management systems. Stringent regulatory compliance requirements further stimulate market growth as pharmacies invest in systems ensuring adherence to guidelines. Finally, the integration of advanced technologies such as artificial intelligence and machine learning is enhancing system functionalities, leading to more accurate forecasting, optimized workflows, and better patient care. The market is segmented by component (solutions and services), deployment (cloud and on-premise), and type (retail, hospital, and other pharmacies). While cloud-based solutions are gaining traction due to their flexibility and accessibility, on-premise systems continue to hold a significant market share, especially in larger hospital settings prioritizing data security. The retail pharmacy segment dominates the market due to its sheer volume, while the hospital pharmacy segment is characterized by higher average system spending reflecting the complexity of their operations. Key players like McKesson, Cerner, and Omnicell are actively shaping the market landscape through technological innovations, strategic partnerships, and acquisitions. The market’s projected CAGR of 9.38% from 2019 to 2033 indicates significant potential for future growth, especially considering the ongoing digital transformation within the healthcare sector and the increasing focus on improving patient outcomes. Recent developments include: Jun 2022: CerTest Biotec collaborated with BD on the Molecular Diagnostic Test for Monkeypox. As part of the collaboration, the assay will leverage the BD MAX open system reagent suite to validate the CerTest VIASURE Monkeypox CE/IVD molecular test on the BD MAX System. The BD MAX System is a fully integrated, automated platform that performs nucleic acid extraction and real-time PCR, providing results for up to 24 samples across multiple syndromes in less than three hours., May 2022: ValGenesis Inc., a provider of enterprise Validation Lifecycle Management Systems (VLMS), and Zenovative, a technology development and consulting firm based in Maryland, the United States, teamed up to provide pharmaceutical companies around the world with unique compliance-focused digital validation solutions.. Key drivers for this market are: Burden on Pharmacists due to the Increasing Number of Prescriptions, Recent Innovations and the Launch of Automated Dispensing Systems. Potential restraints include: Burden on Pharmacists due to the Increasing Number of Prescriptions, Recent Innovations and the Launch of Automated Dispensing Systems. Notable trends are: Solution Segment to Hold a Major Share.

Objective: Pharmacists in over half of the United States can prescribe contraceptives; however, low pharmacist adoption has impeded the full realization of potential public health benefits. Many barriers to adoption may be addressed by leveraging an electronic health records (EHR) system with clinical decision support tools and workflow automation. We conducted a feasibility study to determine if utilizing a contraceptive-specific EHR could improve potential barriers to the implementation of pharmacist-prescribed contraceptive services. Materials and Methods: 20 pharmacists each performed two standardized patient encounter simulations: one on the EHR and one on the current standard of care paper-based workflow. A crossover study design was utilized, with each pharmacist performing encounters on both standardized patients with the modality order randomized. Encounters were timed, contraceptive outputs were recorded, and the pharmacists completed externally validated workload and usability surveys after each encounter, and a Perception, Attitude, and Satisfaction (PAS) survey created by the research team after the final encounter. Results: Pharmacists were more likely to identify contraceptive ineligibility using the EHR-based workflow compared to the paper workflow (p=0.003). Contraceptive encounter time was not significantly different between the two modalities (p=0.280). Pharmacists reported lower mental demand (p=0.003) and greater perceived usefulness (p= 0.029) with the EHR-based workflow compared to the paper modality. Discussion and Conclusion: Pharmacist performance and acceptance of contraceptive services delivery were improved with the EHR workflow. Pharmacist-specific contraceptive EHR workflows show potential to improve pharmacist adoption and provision of appropriate contraceptive care.

--

Methods Twenty US-based pharmacists with active pharmacy licenses and patient care experience were recruited through social media. Each pharmacist completed two standardized contraceptive patient encounters in sequence (referred to here as Patient 1 and Patient 2). To minimize selection bias, an impartial third-party moderator used randomizer software (https://app.studyrandomizer.com) to assign each pharmacist a number between 1-20 and the two study arms were created by dividing the participants into odd and even groups according to the randomized number. . Participants in the odd-numbered group began with the paper-based workflow, while those in even-numbered group began with the EHR workflow. Encounters were timed and contraceptive outputs were recorded by the moderator in an excel spreadsheet using the pharmacist's randomized number and indicating the encounter as Patient 1 or Patient 2. The contraceptive outputs were verified on the paper and electronic medical record documents by the study team. The pharmacists completed externally validated workload and usability surveys after each encounter on paper forms which were photographed and then mailed to the study team using pre-paid packaging. The forms contained the pharmacist's randomized number and the corresponding encounter, Patient 1 vs Patient 2. The study team transcribed the results into the excel spreadsheet. The study team created a Perception, Attitude, and Satisfaction (PAS) survey which was administered to each study participant after the final encounter. The survey was administered electronically by the third party moderator and the results were visible to the study team and transcribed into an excel spreadsheet using the pharmacist's randomized number. The results from the excel spreadsheet were uploaded to R software version 4.2.2 for statistical analysis.

This report was prepared to illustrate the historic and modern relationships between pharmacy as a discipline, settler colonialism, and Indigenous nations. As an early finding from our community engagement with partners, there was an ask from Elders, Knowledge Keepers and community members for our team to prepare a document that identified pharmacy’s contributions to colonization, both past and present. It is intended to serve as a primer, providing context for pharmacy students and professionals to better understand their discipline, its legacy, and its modern-day impacts on Indigenous people, families, and communities. Pharmacists have a responsibility not only to study medication therapy but also to study the history of healthcare and its impacts on Indigenous peoples in particular, who experience significant health disparities when compared to settler populations.1 This report is intended to serve as a starting point for pharmacy students and professionals to begin that understanding and was utilized by our team to ground us, prior to engaging in our project, “Uprooting Pharmacy: A Two-Eyed Seeing Path for Change.”

Snapshot img

Medical Practice Management Software Market Size 2024-2028

The medical practice management software (MPMS) market size is forecast to increase by USD 6.24 billion at a CAGR of 13.73% between 2023 and 2028.

The market is experiencing significant growth, driven by the increasing need for enhanced efficiency and productivity in healthcare organizations. The adoption of advanced MPMS solutions enables streamlined workflows, automated processes, and improved patient care. The integration of advanced technologies, including analytics, is a major trend in the industry, enabling better decision-making and profit optimization. Furthermore, the integration of business intelligence and analytics capabilities into MPMS is a key trend, empowering healthcare providers with valuable insights for informed decision-making. However, the market is not without challenges. Data security and privacy concerns remain a significant hurdle, with the sensitive nature of patient information necessitating strong security measures.
Compliance with various regulations, such as HIPAA and GDPR, adds complexity to the market landscape. To capitalize on the opportunities presented by this dynamic market, companies must focus on addressing these challenges through innovative solutions and rigorous adherence to regulatory requirements. By doing so, they will be well-positioned to help healthcare providers optimize their operations and improve patient outcomes.

What will be the Size of the Medical Practice Management Software (MPMS) Market during the forecast period?

Request Free Sample

The market witnesses a significant rise in consumption due to the increasing demand for efficient and data-driven operations in healthcare clinics and diagnostic centers. The market is growing rapidly as healthcare services increasingly adopt these solutions to streamline operations, improve patient care, and enhance administrative efficiency. The market's current status reflects a mature industry, with a substantial value of production and a large sales volume. Cloud-based MPMS solutions have gained prominence, enabling easy accessibility, scalability, and cost savings for healthcare providers. The market's growth is driven by the need to manage and analyze large volumes of patient data, streamline workflows, and improve overall operational efficiency.
Data mining and analytics capabilities offer valuable growth opportunities, allowing healthcare organizations to gain insights and make informed decisions. Despite these advancements, the market faces challenges related to data security and privacy concerns, requiring continuous investment in strong security measures. Overall, the market continues to evolve, offering primary materials for the development of innovative solutions that cater to the unique needs of healthcare providers.

How is the Medical Practice Management Software (MPMS) Industry segmented?

The industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

Deployment

  Cloud-based
  On-premises


End-user

  Hospitals
  Diagnostic laboratories
  Physicians
  Pharmacists


Geography

  North America

    US


  Europe

    France
    Germany


  APAC

    China
    Japan


  South America



  Middle East and Africa

By Deployment Insights

The cloud-based segment is estimated to witness significant growth during the forecast period. The market is experiencing significant growth, particularly in the cloud-based segment. Cloud-based solutions offer several advantages over traditional on-premises systems, including predictable expenses, no need for a powerful local server, no maintenance fees, and low IT personnel costs. The shift towards cloud-based solutions is gaining momentum due to increasing cost pressures in the on-premises industry. Key drivers of this growth include the adoption of data-driven growth opportunities, rising integration of MPMS with other healthcare IT solutions, and the increasing sales volume in various end-use sectors such as clinics, hospitals, diagnostic centers, and ambulatory surgery centers.

Additionally, insurance payers and hospitals are increasingly turning to MPMS for medical billing and claim management, further fueling market growth. The consumption of MPMS is expected to continue surging as healthcare providers seek to improve efficiency, reduce costs, and enhance patient care.

Get a glance at the market report of share of various segments Request Free Sample

The Cloud-based segment was valued at USD 1.93 billion in 2018 and showed a gradual increase during the forecast period.

Regional Analysis

APAC is estimated to contribute 37% to the growth of the global market during the forecast period. Technavio's analysts have elaborately

Snapshot img

Glove Box Market Size 2024-2028

The glove box market size is forecast to increase by USD 142.2 million at a CAGR of 11.3% between 2023 and 2028.

In the healthcare and pharmaceutical industries, the demand for glove boxes is on the rise due to the increasing importance of maintaining laboratory safety standards during the handling of infectious disease agents and sensitive materials. Pharmacists and pharmacy technicians are key operators in this field, utilizing glove boxes to ensure the safe preparation and dispensing of drugs. The market is witnessing a trend towards adopting automated glove box systems, which enhance efficiency and reduce the risk of human error. However, the use of glove boxes also presents certain challenges, including the need for stringent biosafety measures and adherence to laboratory safety standards. These factors are driving market growth and innovation in the development of advanced glove box technologies. The gloves used in these applications must offer excellent chemical resistance and abrasion resistance to ensure the safety and efficiency of the operators.

What will be the Size of the Market During the Forecast Period?

Request Free Sample

The market encompasses the supply of sealed containers designed to provide a controlled environment for the safe handling of various materials. These containers, also known as glove boxes or laminar flow cabinets, offer operators a means to manipulate hazardous substances, radioactive materials, infectious disease agents, and other sensitive materials in a protected environment. Glove boxes are essential in industries such as pharmaceuticals, healthcare, and laboratories where the containment and protection of materials are critical. They come in various sizes, materials, and designs, including stainless steel and plastic constructions, to accommodate different applications.
One of the primary functions of a glove box is to maintain a moisture-free inert atmosphere within the container. This is crucial for preserving the integrity of the materials being handled and preventing reactions that could compromise their quality. The use of lithium-ion battery technology ensures the reliable operation of vacuum pumps and other essential equipment, maintaining the desired atmosphere. Quality control is paramount in the market. The containers are designed with clear acrylic materials for enhanced visibility, allowing operators to closely monitor their work.

How is this market segmented and which is the largest segment?

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

Type

  Isolation glove box
  Filtered containment glove box


Geography

  North America

    US


  Europe

    Germany
    UK


  APAC

    China
    Japan


  South America



  Middle East and Africa

By Type Insights

The isolation glove box segment is estimated to witness significant growth during the forecast period. In the realm of controlled environments, a Glove Box, specifically a Rigid-Plastic Glove Box, serves as a vital tool for handling substances under specified conditions. These boxes are predominantly employed in cleanrooms and laboratories for the manufacturing and testing of pharmaceuticals, biologicals, chemicals, and microelectronics. The need for these isolation glove boxes arises from their ability to maintain a controlled atmosphere, typically filled with inert gases like argon or nitrogen, for manipulating toxic or high-purity substances. The pharmaceutical industry's increasing number of clinical trials fuels the demand for these boxes. Constructed primarily from stainless steel, they are fabricated using the Tungsten Inert Gas (TIG) welding method.
Moreover, transparent clear acrylic parts are sometimes replaced with tempered glass or other materials to enhance operator safety. Glove boxes are engineered to provide chemical and abrasion resistance, ensuring the contained substances remain unaltered during loading and unloading processes. The clear acrylic material allows operators to view the contents within, enhancing efficiency and precision in their tasks.

Get a glance at the market report of share of various segments Request Free Sample

The isolation glove box segment was valued at USD 138.40 million in 2018 and showed a gradual increase during the forecast period.

Regional Analysis

North America is estimated to contribute 45% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

For more insights on the market share of various regions Request Free Sample

The market is experiencing expansion in the North American reg